BioNano Genomics Inc vs Global X Robo Global Robotics & Automation ETF — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.20M), while Global X Robo Global Robotics & Automation ETF trades at $80.65. The key difference: Global X Robo Global Robotics & Automation ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | ROBO | |
|---|---|---|
Market Cap | $13.20M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.92 | $90.34 |
52-Week Low | $1.09 | $60.15 |
Enterprise Value | $15.81M | — |
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
ROBO, the ROBO Global Robotics and Automation Index ETF, trades at $80.56, down 2.89% over 24 hours amid a bearish technical signal. Key support lies at $79, with resistance at $82. Recent news highlights its diversified AI-driven portfolio and a rebalance toward AI infrastructure, though valuation metrics are not provided in the snapshot. The ETF's performance reflects sector-specific momentum and exposure to cyclical markets like automotive.
Outlook remains mixed; the ETF offers growth exposure to robotics and AI themes, but bearish technical indicators and cyclical risks warrant caution. Investment appeal hinges on sustained AI adoption, while risks include market volatility and competitive pressures in the technology sector.
Trailing returns across standard periods
Latest headlines on both assets
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →